Literature DB >> 21159009

Deposition of hyperphosphorylated tau in cerebellum of PS1 E280A Alzheimer's disease.

Diego Sepulveda-Falla1, Jakob Matschke, Christian Bernreuther, Christian Hagel, Berta Puig, Andres Villegas, Gloria Garcia, Julian Zea, Baltazar Gomez-Mancilla, Isidre Ferrer, Francisco Lopera, Markus Glatzel.   

Abstract

Early-onset familial Alzheimer's disease (AD) caused by presenilin-1 mutation E280A (PS1-E280A) presents wide clinical and neuropathological variabilities. We characterized clinically and neuropathologically PS1-E280A focusing in cerebellar involvement and compared it with early-onset sporadic Alzheimer's disease (EOSAD). Twelve E280A brains and 12 matched EOSAD brains were analyzed for beta-amyloid and hyperphosphorylated tau (pTau) morphology, beta-amyloid subspecies 1-40, 1-42 levels, pTau levels, and expression of stress kinases in frontal cortex and cerebellum. The data were correlated to clinical and genetic findings. We observed higher beta-amyloid load, beta-amyloid 1-42 and pTau concentrations in frontal cortex of PS1-E280A compared with EOSAD. High beta-amyloid load was found in the cerebellum of PS1-E280A and EOSAD patients. In PS1-E280A, beta-amyloid localized to the molecular and Purkinje cell layers, whereas EOSAD showed them in Purkinje and granular cell layers. Surprisingly, 11 out of 12 PS1-E280A patients showed deposition of pTau in the cerebellum. Also, seven out of 12 PS1-E280A patients presented cerebellar ataxia. We conclude that deposition of beta-amyloid in the cerebellum is prominent in early-onset AD irrespective of genetic or sporadic origin. The presence of pTau in cerebellum in PS1-E280A underscores the relevance of cerebellar involvement in AD and might be correlated to clinical phenotype.
© 2011 The Authors; Brain Pathology © 2011 International Society of Neuropathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21159009     DOI: 10.1111/j.1750-3639.2010.00469.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  22 in total

1.  Loss of deep cerebellar nuclei neurons in the 3xTg-AD mice and protection by an anti-amyloid β antibody fragment.

Authors:  Gisela Esquerda-Canals; Joaquim Marti; Geovanny Rivera-Hernández; Lydia Giménez-Llort; Sandra Villegas
Journal:  MAbs       Date:  2013-06-20       Impact factor: 5.857

2.  Squirrel monkeys (Saimiri sciureus) infected with the agent of bovine spongiform encephalopathy develop tau pathology.

Authors:  P Piccardo; J Cervenak; O Yakovleva; L Gregori; K Pomeroy; A Cook; F S Muhammad; T Seuberlich; L Cervenakova; D M Asher
Journal:  J Comp Pathol       Date:  2011-10-20       Impact factor: 1.311

3.  Complex proteinopathy with accumulations of prion protein, hyperphosphorylated tau, α-synuclein and ubiquitin in experimental bovine spongiform encephalopathy of monkeys.

Authors:  Pedro Piccardo; Juraj Cervenak; Ming Bu; Lindsay Miller; David M Asher
Journal:  J Gen Virol       Date:  2014-04-25       Impact factor: 3.891

4.  A novel interaction between aging and ER overload in a protein conformational dementia.

Authors:  Angela Schipanski; Sascha Lange; Alexandra Segref; Aljona Gutschmidt; David A Lomas; Elena Miranda; Michaela Schweizer; Thorsten Hoppe; Markus Glatzel
Journal:  Genetics       Date:  2013-01-18       Impact factor: 4.562

5.  Early-onset familial Alzheimer's disease related to presenilin 1 mutation resembling autosomal dominant spinocerebellar ataxia.

Authors:  Pedro Braga-Neto; José Luiz Pedroso; Helena Alessi; Paulo Victor Sgobbi de Souza; Paulo Henrique Ferreira Bertolucci; Orlando Graziani Povoas Barsottini
Journal:  J Neurol       Date:  2013-03-13       Impact factor: 4.849

6.  Familial Alzheimer's disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis.

Authors:  Diego Sepulveda-Falla; Alvaro Barrera-Ocampo; Christian Hagel; Anne Korwitz; Maria Fernanda Vinueza-Veloz; Kuikui Zhou; Martijn Schonewille; Haibo Zhou; Luis Velazquez-Perez; Roberto Rodriguez-Labrada; Andres Villegas; Isidro Ferrer; Francisco Lopera; Thomas Langer; Chris I De Zeeuw; Markus Glatzel
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

7.  Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.

Authors:  Yakeel T Quiroz; Reisa A Sperling; Daniel J Norton; Ana Baena; Joseph F Arboleda-Velasquez; Danielle Cosio; Aaron Schultz; Molly Lapoint; Edmarie Guzman-Velez; John B Miller; Leo A Kim; Kewei Chen; Pierre N Tariot; Francisco Lopera; Eric M Reiman; Keith A Johnson
Journal:  JAMA Neurol       Date:  2018-05-01       Impact factor: 18.302

8.  Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database.

Authors:  John M Ringman; Sarah Monsell; Denise W Ng; Yan Zhou; Andy Nguyen; Giovanni Coppola; Victoria Van Berlo; Mario F Mendez; Spencer Tung; Sandra Weintraub; Marek-Marsel Mesulam; Eileen H Bigio; Darren R Gitelman; Amanda O Fisher-Hubbard; Roger L Albin; Harry V Vinters
Journal:  J Neuropathol Exp Neurol       Date:  2016-02-17       Impact factor: 3.685

9.  AMPK activation does not enhance autophagy in neurons in contrast to MTORC1 inhibition: different impact on β-amyloid clearance.

Authors:  Irene Benito-Cuesta; Lara Ordóñez-Gutiérrez; Francisco Wandosell
Journal:  Autophagy       Date:  2020-02-20       Impact factor: 16.016

10.  Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease.

Authors:  Marta Pera; Daniel Alcolea; Raquel Sánchez-Valle; Cristina Guardia-Laguarta; Martí Colom-Cadena; Nahuai Badiola; Marc Suárez-Calvet; Albert Lladó; Alvaro A Barrera-Ocampo; Diego Sepulveda-Falla; Rafael Blesa; José L Molinuevo; Jordi Clarimón; Isidre Ferrer; Ellen Gelpi; Alberto Lleó
Journal:  Acta Neuropathol       Date:  2012-12-06       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.